All Stories

  1. Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India
  2. Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis
  3. Reduced incidence of extra-articular manifestations of RA through effective disease control: Karnataka Rheumatoid Arthritis Comorbidity (KRAC) study
  4. Factors influencing remission in rheumatoid arthritis patients: results from Karnataka rheumatoid arthritis comorbidity ( KRAC ) study
  5. Role of vitamin D supplementation in improving disease activity in rheumatoid arthritis: An exploratory study
  6. Current studies of biomarkers for the early diagnosis of rheumatoid arthritis
  7. OP0012 A Phase 3, Randomized, Double-Blind, Active Comparator Study of the Efficacy and Safety of Bow015, A Biosimilar Infliximab, in Patients with Active Rheumatoid Arthritis on Stable Methotrexate Doses
  8. Variation in pressure pain threshold correlates with rheumatoid arthritis disease activity, not with the inflammatory parameters
  9. Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers
  10. Pharmacokinetic consideration of synthetic DMARDs in rheumatoid arthritis
  11. Remission occurs still only in minority of rheumatoid arthritis while a tight control is achievable in a routine clinical practice – A cross section study
  12. Serum levels of interleukin-13 and interferon-gamma from adult patients with asthma in Mysore
  13. Measures in rheumatoid arthritis: are we measuring too many parameters
  14. ESR or CRP, which inflammatory measure can accurately replace clinical measures in rheumatoid arthritis?
  15. Sample size estimation and power analysis for clinical research studies
  16. The treatment strategies of autoimmune disease may need a different approach from conventional protocol: A review
  17. O8 Change in pain pressure threshold reflects disease activity but does not correlate to inflammatory parameter in rheumatoid arthritis
  18. P9 Remission occurs still only in minority while a tight control is achievable
  19. P72 C-reactive protein normal level—a systematic meta-analysis
  20. P22 Measure of association between the presence of Ro60, Ro52 and La48 auto-antibodies and various clinical manifestations
  21. Complementary and alternative medicine in rheumatoid arthritis
  22. Can bronchial asthma be classified based on the immunological status?
  23. P21 ESR or CRP, which inflammatory measure is accurate in rheumatoid arthritis?
  24. P28 ESR or corrected ESR—factors influencing in a routine measures
  25. Evaluation of efficacy of combination of methotrexate and hydroxychloroquine with leflunomide in active rheumatoid arthritis
  26. Evaluation of serum immunoglobulin E levels in bronchial asthma
  27. P16 Are Auto antibodies enough proof for Sjogren syndrome diagnosis?
  28. P80 Spondyloepiphyseal dysplasia mimiking juvenile rheumatoid arthritis
  29. P17 Altered cognitive response to pain in addition to the altered pain threshold in fibromyalgia patients than normal and rheumatoid arthritis
  30. Influence of yoga on postoperative outcomes and wound healing in early operable breast cancer patients undergoing surgery
  31. Influence of yoga on mood states, distress, quality of life and immune outcomes in early stage breast cancer patients undergoing surgery
  32. Cytokine response to strenuous exercise in athletes and non-athletes—an adaptive response
  33. P35 Patients anxiety has a significant influence on patient derived measures in rheumatoid arthritis
  34. P37 Unusual presentation of 2 cases of homocystinaemia in musculoskeletal diseases clinic
  35. O1 Rheumatoid factor and Anti-CCP in rheumatoid arthritis
  36. P31 Visual analogue scale over represent pain in comparison to pressure pain threshold in both fibromyalgia and in normal subjects
  37. Effects of anxiety on TNF-α levels during psychological stress
  38. P29 Increased incidence of co-morbid condition in psoriatic arthritis patients
  39. P30 Rheumatoid arthritis with ulcerative colitis—a case report
  40. P27 Evaluation of efficacy of leflunomide with combination of methotrexate and hydroxychloroquine in the treatment of rheumatoid arthritis
  41. P32 A retrospective analysis of seronegative spondyloarthropathies (SpA), its clinical manifestations does not depend on the HLA B27 status
  42. Is three selected parameters adequate to monitor rheumatoid arthritis?
  43. Do Baseline IL-6 Levels Predict Post-operative Morbidity After Surgery (CABG) in Cardiac Patients?
  44. Role of Anticyclic Citrullinated Peptide in the Diagnosis of Early Rheumatoid Factor-Negative Suspected Rheumatoid Arthritis
  45. The incidence of Proteus mirabilis infection increases in patients on treatment but does not trigger disease activity
  46. Changes in plasma glucose levels and tumor necrosis factor alfa (tnf- α) with graded and regular exercise: Does this have an impact on patients of diabetes mellitus?
  47. Congenital flexion deformity of the wrist owing to an anomalous insertion of the flexor carpi ulnaris: a case report
  48. Proteus mirabilis and rheumatoid arthritis: no association with the disease